311 related articles for article (PubMed ID: 26173433)
1. YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors.
Marti P; Stein C; Blumer T; Abraham Y; Dill MT; Pikiolek M; Orsini V; Jurisic G; Megel P; Makowska Z; Agarinis C; Tornillo L; Bouwmeester T; Ruffner H; Bauer A; Parker CN; Schmelzle T; Terracciano LM; Heim MH; Tchorz JS
Hepatology; 2015 Nov; 62(5):1497-510. PubMed ID: 26173433
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
Kitagawa K; Moriya K; Kaji K; Saikawa S; Sato S; Nishimura N; Namisaki T; Akahane T; Mitoro A; Yoshiji H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066548
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in Cholangiocarcinoma.
Zhang Y; Xu H; Cui G; Liang B; Chen X; Ko S; Affo S; Song X; Liao Y; Feng J; Wang P; Wang H; Xu M; Wang J; Pes GM; Ribback S; Zeng Y; Singhi A; Schwabe RF; Monga SP; Evert M; Tang L; Calvisi DF; Chen X
Gastroenterology; 2022 Aug; 163(2):481-494. PubMed ID: 35489428
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of Hippo kinase signalling in human hepatic malignancies.
Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
Saikawa S; Kaji K; Nishimura N; Seki K; Sato S; Nakanishi K; Kitagawa K; Kawaratani H; Kitade M; Moriya K; Namisaki T; Mitoro A; Yoshiji H
Cancer Lett; 2018 Oct; 434():120-129. PubMed ID: 30031758
[TBL] [Abstract][Full Text] [Related]
7. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways.
Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W
Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475
[TBL] [Abstract][Full Text] [Related]
8. MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway.
Li JH; Zhu XX; Li FX; Huang CS; Huang XT; Wang JQ; Gao ZX; Li SJ; Xu QC; Zhao W; Yin XY
J Exp Clin Cancer Res; 2019 Nov; 38(1):476. PubMed ID: 31775892
[TBL] [Abstract][Full Text] [Related]
9. TGR5 promotes cholangiocarcinoma by interacting with mortalin.
Li AD; Xie XL; Qi W; Wang WB; Ma JJ; Zhao DQ; Jiang XY; Chen L; Bai Y; Jiang HQ
Exp Cell Res; 2020 Apr; 389(2):111855. PubMed ID: 31978385
[TBL] [Abstract][Full Text] [Related]
10. Snapshots of a hybrid transcription factor in the Hippo pathway.
Luo X
Protein Cell; 2010 Sep; 1(9):811-9. PubMed ID: 21203923
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
[TBL] [Abstract][Full Text] [Related]
12. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
[TBL] [Abstract][Full Text] [Related]
13. TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma.
Xiao H; Tong R; Yang B; Lv Z; Du C; Peng C; Ding C; Cheng S; Zhou L; Xie H; Wu J; Zheng S
Cancer Lett; 2016 Oct; 381(2):370-9. PubMed ID: 27554639
[TBL] [Abstract][Full Text] [Related]
14. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
15. YAP regulates neural progenitor cell number via the TEA domain transcription factor.
Cao X; Pfaff SL; Gage FH
Genes Dev; 2008 Dec; 22(23):3320-34. PubMed ID: 19015275
[TBL] [Abstract][Full Text] [Related]
16. Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma.
Li S; Yang H; Li K; Fan G; Deng L; Xu C
Cell Biochem Funct; 2020 Aug; 38(6):743-752. PubMed ID: 32476180
[TBL] [Abstract][Full Text] [Related]
17. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP.
Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140
[TBL] [Abstract][Full Text] [Related]
18. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
20. Hippo pathway effector Yap is an ovarian cancer oncogene.
Hall CA; Wang R; Miao J; Oliva E; Shen X; Wheeler T; Hilsenbeck SG; Orsulic S; Goode S
Cancer Res; 2010 Nov; 70(21):8517-25. PubMed ID: 20947521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
